Next Generation Rocklatan

• Status: ACTIVE_NOT_RECRUITING
• Trial end date: 2025-11-01

Summary

The purpose of this two-stage clinical trial is to assess the safety and hypotensive efficacy of AR-17043 and PG043 ophthalmic solutions in subjects with open-angle glaucoma (OAG) or ocular hypertension (OHT).

• Phase: PHASE2

Details

• Lead Sponsor: Alcon Research
• Treatments: Latanoprost; netarsudil; Ophthalmic Solutions